Pablo Canales-Herrerias

Postdoc at @Mehandrulab & Cerutti labs at @IcahnMountSinai. Mucosal #Bcell responses & #HIV. Previously @institutpasteur @JohnsHopkins. @pabloimmune.bsky.social

[Pablo Canales-Herrerias @pabloimmune]

Excited to share our new work in @SciImmunology! We describe targeting of gut-associated lymphoid tissue (GALT) as a novel mode of action of anti-α4β7 therapy in IBD. Co-led by @mat_uzz & A. Seki @MehandruLab @SinaiImmunol @MountSinaiGI @IcahnMountSinai🧵
https://t.co/84ltXHiUv4

[Journal of Experimental Medicine @JExpMed]

New study from @RoserTP, @HabibBashour, Filipska, et al. (@victorgreiff & Cerutti labs @UniOslo & @HMar_research) show IgD responses involve a heterogenous population of IgD class-switched memory #Bcells from epithelial areas of the aerodigestive mucosa. https://t.co/pNPOtXET0A

[GiulianaMagri @GMagri_Immuno]

📢 Looking for a #MasterThesis (TFM) opportunity?
Join our lab at University of Barcelona! 🧬Project: Host–microbiota interaction in Crohn’s disease : from systems immunology to antibody engineering.
🔗Contact us to learn more! #translationalImmunology #Microbiome #antibodies

[Shailaja Seetharaman @shailajaseethar]

My lab @MBIsg and @NUSMedicine is recruiting a fully-funded postdoc to start in Jan 2026! Interested in cell and tissue mechanics, transcriptional regulation of tissue health, or AI/ML for disease mechanobiology? Come join us in Singapore!
https://t.co/qoZz02LPDY

[Shailaja Seetharaman @shailajaseethar]

Excited to be starting my research group as a tenure track Presidential Young Professor at the Mechanobiology Institute @MBIsg, and the Dept of Physiology at @NUSingapore in the fall! More about our work on vascular mechanobiology: https://t.co/2PDzYxiE5F

[FIRA - Eyer Group - Aarhus University @EyerFira]

Interested in pursuing a PhD thesis in our group in Demark? Interested in droplets, immune cells and cellular functions? Then definitely apply!
https://t.co/GhklNCovOV

[GiulianaMagri @GMagri_Immuno]

Please RT 🙏!📢My lab at @UniBarcelona is seeking a highly motivated postdoc to lead an exciting new public-private collaborative project (UB, CRG, CSIC, OrikineBio) aimed at testing a potentially game-changing therapy for IBD. If interested, please contact me at [email protected].

[Waggoner Lab @LabWaggoner]

Intestinal germinal center B cell reduction in HIV-1 infection is linked to reduced IgA+ plasma cells and systemic inflammation @SciImmunology @francescacossa1 @saurabhmehandru
https://t.co/0A6BWKRGoc

[Pablo Canales-Herrerias @pabloimmune]

Check this out from @francescacossa1 and @MehandruLab 🔥🔥 @SinaiImmunol @MountSinaiGI @SciImmunology 👇

[Science Immunology @SciImmunology]

New research from @MehandruLab describes the depletion of germinal center B cells and IgA+ plasma cells in the #GI tracts of people living with #HIV. @francescacossa1

Read more in Science #Immunology: https://t.co/AddkkyWKbD

[Pablo Canales-Herrerias @pabloimmune]

@perlmannlab 🤞for Max Cooper and Jacques Miller

[Institut Pasteur, since 1887 @institutpasteur]

🎉 Applications are open for the 2025 Pasteur-Paris University PhD Program (PPU)!

Join a global community of researchers and contribute to groundbreaking biomedical discoveries.

📅 Deadline: October 27, 2024

🔗 Apply now: https://t.co/q9rGArH4iR

#research #institutpasteur

[Icahn School of Medicine at Mount Sinai @IcahnMountSinai]

According to a Mount Sinai study, Vedolizumab, a mainstay drug for managing ulcerative colitis, appears to work by targeting gut-associated lymphoid tissue.

Read more: https://t.co/DKHcTu23TI

@DOMSinaiNYC @MountSinaiGI #IBD

[Konnikova lab @LizaKonnikova]

We are looking for post-docs. Interested in early life human immunity and bioinformatics? We have a number of really interesting projects. Spread the word and please apply! @YalePediatrics @YaleIBIO

[Pablo Canales-Herrerias @pabloimmune]

@JeanFredericCo1 🇫🇷🍾🥂

[Pablo Canales-Herrerias @pabloimmune]

Front-line drug for ulcerative colitis found to have additional mechanism of action that until now remained elusive https://t.co/iQfNCgLCS8 via @medical_xpress

[The Colitist @colitist]

Front-line drug for ulcerative colitis found to have additional mechanism of action that until now remained elusive (Vdz) https://t.co/1BLhPWquIO via @medical_xpress

[Arno Bourgonje @BourgonjeArno]

Out now 🚨 in @AGA_Gastro is your latest update on selective IL-23p19 inhibition in IBD! Amongst other topics featuring discussion of pathogenesis, PD/PK, efficacy, safety, positioning, and more! Together with @JeanFredericCo1 @MehandruLab & @ryanungaro https://t.co/E6ac1n4Zf8

[Pablo Canales-Herrerias @pabloimmune]

@shailajaseethar Congrats @shailajaseethar!!

[Pablo Canales-Herrerias @pabloimmune]

@BourgonjeArno @EdelblumLab @MountSinaiGI @JeanFredericCo1 @ryanungaro @DrMikeDolinger @bruce_sands1 @IBDebrief @MSHS_IBDCenter @MehandruLab @a_livanos 🤣